Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response
We report a 31-year-old woman with chemotherapy –refractory metastatic osteosarcoma who was successfully treated with the com...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Hanna E. Persha, Shumei Kato, Pradip De, Jacob J. Adashek, Jason K. Sicklick, Vivek Subbiah and Razelle Kurzrock Tags: Correspondence Source Type: research